[P27 expression and survival in NSCLC].
Hirabayashi
Hirohisa
H
Department of Surgery, Osaka University Graduate School of Medicine.
D014408:Biomarkers, Tumor / Q000032:analysis*; D002289:Carcinoma, Non-Small-Cell Lung / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D002453:Cell Cycle; D018797:Cell Cycle Proteins / Q000032:analysis* / Q000502:physiology; D050760:Cyclin-Dependent Kinase Inhibitor p27; D003937:Diagnosis, Differential; D006801:Humans; D008175:Lung Neoplasms / Q000175:diagnosis* / Q000401:mortality / Q000473:pathology / Q000628:therapy; D011379:Prognosis; D015996:Survival Rate; D025521:Tumor Suppressor Proteins / Q000032:analysis* / Q000502:physiology
D014408:Biomarkers, Tumor; D018797:Cell Cycle Proteins; D025521:Tumor Suppressor Proteins; D050760:Cyclin-Dependent Kinase Inhibitor p27